{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:57:03Z","timestamp":1793048223254,"version":"4.5.0"},"reference-count":286,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI050875"],"award-info":[{"award-number":["R01AI050875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI121700"],"award-info":[{"award-number":["R21AI121700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijbiomac.2022.02.094","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:34:10Z","timestamp":1645554850000},"page":"435-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Transforming growth factor-beta (TGF-\u03b2) in prostate cancer: A dual function mediator?"],"prefix":"10.1016","volume":"206","author":[{"given":"Sepideh","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid Deldar Abad","family":"Paskeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Saghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Aref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Rabiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Ashrafizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0005","first-page":"3099","article-title":"Transforming growth factor-\u03b2: a multifunctional regulator of cancer immunity","volume":"12","author":"Xue","year":"2020"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb0010","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/1878-0261.12779","article-title":"TGF-\u03b2-induced IGFBP-3 is a key paracrine factor from activated pericytes that promotes colorectal cancer cell migration and invasion","volume":"14","author":"Navarro","year":"2020","journal-title":"Mol. Oncol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2022.02.094_bb0015","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","article-title":"TGF-\u03b21 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation","volume":"39","author":"Cave","year":"2020","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.02.094_bb0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-019-03595-8","article-title":"TGF-\u03b22 antagonizes IL-6-promoted cell survival","volume":"461","author":"Du","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0025","doi-asserted-by":"crossref","first-page":"4180857","DOI":"10.1155\/2018\/4180857","article-title":"Type III transforming growth factor-\u03b2 receptor RNA interference enhances transforming growth factor \u03b23-induced chondrogenesis signaling in human mesenchymal stem cells","volume":"2018","author":"Zheng","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0030","series-title":"Roles of TGF-\u03b2 Signaling Pathway in Tumor Microenvirionment and Cancer Therapy","volume":"89","author":"Zhao","year":"2020"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0035","first-page":"190","article-title":"TGF-\u03b2 latency: biological significance and mechanisms of activation","volume":"15","author":"Gleizes","year":"1997"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0040","first-page":"1376","article-title":"Latent transforming growth factor-\u03b2: structural features and mechanisms of activation","volume":"51","author":"Munger","year":"1997"},{"issue":"570","key":"10.1016\/j.ijbiomac.2022.02.094_bb0045","article-title":"Specificity, versatility, and control of TGF-\u03b2 family signaling","volume":"12","author":"Derynck","year":"2019"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0050","first-page":"51","article-title":"TGF-\u03b2 activation and function in immunity","volume":"32","author":"Travis","year":"2014"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0055","first-page":"924","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019"},{"issue":"7351","key":"10.1016\/j.ijbiomac.2022.02.094_bb0060","first-page":"343","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0065","first-page":"1129","article-title":"GARP regulates the bioavailability and activation of TGF\u03b2","volume":"23","author":"Wang","year":"2012"},{"issue":"536","key":"10.1016\/j.ijbiomac.2022.02.094_bb0070","article-title":"Selective inhibition of TGF\u03b21 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape","volume":"12","author":"Martin","year":"2020"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0075","first-page":"1666","article-title":"Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts","volume":"10","author":"Shi","year":"2020"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0080","first-page":"4002","article-title":"Association of the epithelial\u2013mesenchymal transition (EMT) with cisplatin resistance","volume":"21","author":"Ashrafizadeh","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0085","first-page":"261","article-title":"Resveratrol modulates transforming growth factor-Beta (TGF-\u03b2) signaling pathway for disease therapy:a new insight into its pharmacological activities","volume":"8","author":"Ashrafizadeh","year":"2020"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0100","series-title":"Role of Glycosylation in TGF-\u03b2 Signaling and Epithelial-to-mesenchymal Transition in Cancer","first-page":"1","author":"Zhang","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0105","first-page":"111046","article-title":"Recent progress in TGF-\u03b2 inhibitors for cancer therapy","volume":"134","author":"Huang","year":"2021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0110","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1038\/s41467-019-12241-2","article-title":"C-met activation leads to the establishment of a TGF\u03b2-receptor regulatory network in bladder cancer progression","volume":"10","author":"Sim","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081159","article-title":"Role of microRNA\/Epithelial-to-mesenchymal transition Axis in the metastasis of bladder cancer","volume":"10","author":"Ashrafizadeh","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0120","first-page":"1745","article-title":"Transcriptional control by the TGF-\u03b2\/Smad signaling system","volume":"19","author":"Massagu\u00e9","year":"2000"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0125","first-page":"685","article-title":"Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1440-1681.13582","article-title":"Berberine inhibits non\u2010small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis","volume":"49","author":"Ni","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2008.302","article-title":"Signaling cross-talk between TGF-beta\/BMP and other pathways","volume":"19","author":"Guo","year":"2009","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-020-01235-0","article-title":"Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p\/miR-506-3p- TGF-\u03b21 axis","volume":"19","author":"Shang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12894-020-00663-w","article-title":"LncRNA PLAC2 upregulates miR-663 to downregulate TGF-\u03b21 and suppress bladder cancer cell migration and invasion","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Urol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145154","article-title":"Silencing circ_0062389 alleviates cardiomyocyte apoptosis in heart failure rats via modulating TGF-\u03b21\/Smad3 signaling pathway","volume":"766","author":"Zhang","year":"2021","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0160","first-page":"2672","article-title":"Long non-coding RNAs and TGF-\u03b2 signaling in cancer","volume":"111","author":"Papoutsoglou","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0165","series-title":"Multifaceted Transforming Growth Factor-beta (TGF\u03b2) Signalling in Glioblastoma","author":"Birch","year":"2020"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CAD.0000000000000328","article-title":"Potential role of targeted therapies in the treatment of triple-negative breast cancer","volume":"27","author":"Jia","year":"2016","journal-title":"Anti-Cancer Drugs"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071601","article-title":"Bergamottin suppresses metastasis of lung cancer cells through abrogation of diverse oncogenic signaling cascades and epithelial-to-mesenchymal transition","volume":"23","author":"Ko","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081584","article-title":"Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K\/Akt\/mTOR signaling cascade","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"issue":"7832","key":"10.1016\/j.ijbiomac.2022.02.094_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2836-1","article-title":"TGF-\u03b2 suppresses type 2 immunity to cancer","volume":"587","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0190","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.2147\/OTT.S278013","article-title":"Progress in understanding the IL-6\/STAT3 pathway in colorectal cancer","volume":"13","author":"Lin","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0195","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00262-020-02542-7","article-title":"Combined blockade of TGf-\u03b21 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment","volume":"69","author":"Liu","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0200","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/ijc.33439","article-title":"Thrombospondin-4 mediates hyperglycemia- and TGF-beta-induced inflammation in breast cancer","volume":"148","author":"Muppala","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118892","article-title":"VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-\u03b2\/ERK\/RSK2 signaling","volume":"1868","author":"Im","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"21","key":"10.1016\/j.ijbiomac.2022.02.094_bb0210","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.7150\/jca.47083","article-title":"MiR-135-5p inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer","volume":"11","author":"Yang","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0215","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3892\/or.2020.7595","article-title":"Metformin inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and liver metastasis of pancreatic cancer cells","volume":"44","author":"Yoshida","year":"2020","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb0220","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3390\/cancers12092459","article-title":"STAT3, the challenge for chemotherapeutic and radiotherapeutic efficacy","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","article-title":"Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer","volume":"38","author":"Gabitova-Cornell","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0230","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1038\/s41467-020-17811-3","article-title":"Selective inhibition of TGF-\u03b21 produced by GARP-expressing tregs overcomes resistance to PD-1\/PD-L1 blockade in cancer","volume":"11","author":"de Streel","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb0235","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/s41418-020-0555-7","article-title":"FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-\u03b2 and miR-182-5p","volume":"27","author":"Lu","year":"2020","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.ijbiomac.2022.02.094_bb0240","first-page":"3068","article-title":"Distant metastases from prostatic carcinoma express androgen receptor protein","volume":"55","author":"Hobisch","year":"1995"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0245","first-page":"129","article-title":"Androgen receptor status of lymph node metastases from prostate cancer","volume":"28","author":"Hobisch","year":"1996"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0250","first-page":"3057","article-title":"Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy","volume":"67","author":"Sadi","year":"1991"},{"issue":"15","key":"10.1016\/j.ijbiomac.2022.02.094_bb0255","first-page":"4096","article-title":"Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis","volume":"54","author":"Tilley","year":"1994"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0260","first-page":"265","article-title":"Androgen receptors in untreated and treated prostatic intraepithelial neoplasia","volume":"30","author":"van der Kwast","year":"1996"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7150\/ijbs.8756","article-title":"Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-myc regulation","volume":"10","author":"Vander Griend","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc1947","article-title":"Lineage dependency and lineage-survival oncogenes in human cancer","volume":"6","author":"Garraway","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.581515","article-title":"Recent discoveries in the androgen receptor pathway in castration-resistant prostate cancer","volume":"10","author":"Obinata","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0280","series-title":"Seminars in Radiation Oncology","article-title":"The role of theranostics in prostate cancer","author":"O'Dwyer","year":"2021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10495-016-1313-7","article-title":"Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer","volume":"22","author":"Zhang","year":"2017","journal-title":"Apoptosis"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0290","doi-asserted-by":"crossref","first-page":"17700","DOI":"10.18632\/oncotarget.10775","article-title":"Capsazepine inhibits JAK\/STAT3 signaling, tumor growth, and cell survival in prostate cancer","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.ijbiomac.2022.02.094_bb0295","first-page":"1502","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004"},{"issue":"9747","key":"10.1016\/j.ijbiomac.2022.02.094_bb0300","first-page":"1147","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"De Bono","year":"2010"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0305","first-page":"213","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0310","first-page":"138","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0315","first-page":"424","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.02.094_bb0320","first-page":"1187","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0325","first-page":"411","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0330","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/ars.2015.6418","article-title":"Nimbolide-induced oxidative stress abrogates STAT3 signaling Cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model","volume":"24","author":"Zhang","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0335","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/pros.22574","article-title":"Embelin inhibits growth and induces apoptosis through the suppression of Akt\/mTOR\/S6K1 signaling cascades","volume":"73","author":"Kim","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/968040","article-title":"Targeting PPAR\u03b3 signaling cascade for the prevention and treatment of prostate cancer","volume":"2012","author":"Sikka","year":"2012","journal-title":"PPAR Res"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0345","first-page":"469","article-title":"Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer","volume":"17","author":"Perera","year":"2020"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0350","article-title":"RNAs as candidate diagnostic and prognostic markers of prostate cancer-from cell line models to liquid biopsies","volume":"8","author":"Lim","year":"2018","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0355","first-page":"221","article-title":"The use of biomarkers in prostate cancer screening and treatment","volume":"19","author":"Alford","year":"2017","journal-title":"Rev. Urol"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0360","first-page":"563","article-title":"Circular RNA and its potential as prostate cancer biomarkers","volume":"11","author":"Tucker","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.03.025","article-title":"Regulation of nuclear factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis?","volume":"509","author":"Mirzaei","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174274","article-title":"Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-\u03baB\/STAT3 signaling cascades","volume":"906","author":"Sikka","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032476","article-title":"Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways","volume":"7","author":"Shanmugam","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0380","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1074\/jbc.RA118.006057","article-title":"Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0385","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/jcm9082680","article-title":"Application of anti-inflammatory agents in prostate cancer","volume":"9","author":"Hatano","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0390","series-title":"Role of MicroRNAs in the Development, Prognosis and Therapeutic Response of Patients With Prostate Cancer","author":"Ghafouri-Fard","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0395","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1093\/nar\/gkz108","article-title":"LncRNA PCAT1 activates AKT and NF-\u03baB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK\u03b1 complex","volume":"47","author":"Shang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0400","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1139\/bcb-2019-0065","article-title":"LncRNA SNHG4 promotes the proliferation, migration, invasiveness, and epithelial-mesenchymal transition of lung cancer cells by regulating miR-98-5p","volume":"97","author":"Tang","year":"2019","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0405","series-title":"PD-1\/PD-L1 Axis Regulation in Cancer Therapy: The Role of Long Non-coding RNAs and MicroRNAs","author":"Ashrafizadeh","year":"2020"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0410","first-page":"549","article-title":"An update on the prognostic and predictive serum biomarkers in metastatic prostate cancer","volume":"10","author":"Saxby","year":"2020"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0415","first-page":"126","article-title":"Prostate-targeted mTOR-shRNA inhibit prostate cancer cell growth in human tumor xenografts","volume":"6","author":"Du","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116586","article-title":"CRISPR\/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells","volume":"231","author":"Rahimi","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0425","article-title":"Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer","volume":"7","author":"Ashrafizadeh","year":"2020","journal-title":"Bioengineering (Basel)"},{"issue":"15","key":"10.1016\/j.ijbiomac.2022.02.094_bb0430","doi-asserted-by":"crossref","first-page":"25115","DOI":"10.18632\/oncotarget.15931","article-title":"TMPRSS2:ERG gene fusion variants induce TGF-\u03b2 signaling and epithelial to mesenchymal transition in human prostate cancer cells","volume":"8","author":"Ratz","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0435","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0045(19970401)31:1<61::AID-PROS10>3.0.CO;2-M","article-title":"TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity","volume":"31","author":"Barrack","year":"1997","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2011.08.034","article-title":"Regulation of TGF-\u03b21 expression by androgen deprivation therapy of prostate cancer","volume":"318","author":"Fuzio","year":"2012","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0445","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bone.2011.11.022","article-title":"Effect of transforming growth factor beta (TGF-\u03b2) receptor I kinase inhibitor on prostate cancer bone growth","volume":"50","author":"Wan","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0450","first-page":"44","article-title":"Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells","volume":"56","author":"Kim","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116791","article-title":"Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-\u03b2 signaling pathway","volume":"235","author":"Sun","year":"2019","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0460","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/pros.22482","article-title":"Increased TGF-\u03b21-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2\/3 signaling","volume":"72","author":"Miles","year":"2012","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0465","first-page":"304","article-title":"Small in size, but large in action: microRNAs as potential modulators of PTEN in","volume":"11","author":"Abadi","year":"2021","journal-title":"Breast Lung Cancers"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0470","first-page":"264","article-title":"PTEN, a barrier for proliferation and metastasis of gastric cancer cells: from molecular pathways to targeting and regulation","volume":"8","author":"Ashrafizadeh","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0475","series-title":"PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?","author":"Ashrafizadeh","year":"2020"},{"issue":"43","key":"10.1016\/j.ijbiomac.2022.02.094_bb0480","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.3748\/wjg.v21.i43.12261","article-title":"Targeting the PI3K\/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine?","volume":"21","author":"Singh","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104504","article-title":"Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt\/mTOR pathway","volume":"150","author":"Lee","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020254","article-title":"Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt\/mTOR signaling cascade","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153155","article-title":"Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K\/Akt\/mTOR signaling pathway","volume":"11","author":"Mohan","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0500","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/pros.23482","article-title":"Differential role of PTEN in transforming growth factor \u03b2 (TGF-\u03b2) effects on proliferation and migration in prostate cancer cells","volume":"78","author":"Kimbrough-Allah","year":"2018","journal-title":"Prostate"},{"issue":"56","key":"10.1016\/j.ijbiomac.2022.02.094_bb0505","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1038\/onc.2008.293","article-title":"Prostate tumor progression is mediated by a paracrine TGF-beta\/Wnt3a signaling axis","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0510","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbrc.2020.05.187","article-title":"Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation","volume":"529","author":"Lv","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0515","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41416-020-01197-6","article-title":"Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer","volume":"124","author":"Nikhil","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.02.094_bb0520","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-20-3258","article-title":"Mutated SPOP E3 ligase promotes 17\u03b2HSD4 protein degradation to drive androgenesis and prostate cancer progression","volume":"81","author":"Shi","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb0525","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.18632\/aging.103085","article-title":"TGF-\u03b2 signaling regulates SPOP expression and promotes prostate cancer cell stemness","volume":"12","author":"Jiao","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0530","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/aja.aja_60_20","article-title":"TGF-\u03b21-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression","volume":"23","author":"Hu","year":"2021","journal-title":"Asian J Androl"},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2022.02.094_bb0535","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.regpep.2009.04.012","article-title":"TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3","volume":"155","author":"Konrad","year":"2009","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0540","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.2147\/OTT.S258252","article-title":"Role of \u03b1V\u03b23 in prostate cancer: metastasis initiator and important therapeutic target","volume":"13","author":"Tang","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0545","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fphar.2018.01294","article-title":"Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis","volume":"9","author":"Shanmugam","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081882","article-title":"Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis","volume":"13","author":"Datta","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.ijbiomac.2022.02.094_bb0555","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1089\/ars.2019.7935","article-title":"Targeting hypoxia-inducible Factor-1-mediated metastasis for cancer therapy","volume":"34","author":"Ma","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0560","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1158\/1940-6207.CAPR-13-0070","article-title":"Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma","volume":"6","author":"Li","year":"2013","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2022.02.094_bb0565","doi-asserted-by":"crossref","first-page":"150","DOI":"10.18632\/genesandcancer.196","article-title":"Genomic alterations of tenascin C in highly aggressive prostate cancer: a meta-analysis","volume":"10","author":"Mishra","year":"2019","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0570","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1038\/s41598-019-47874-2","article-title":"Paradoxical role of Glypican-1 in prostate cancer cell and tumor growth","volume":"9","author":"Quach","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0575","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/molecules26020384","article-title":"Recent advances in nanomedicine for the diagnosis and treatment of prostate cancer bone metastasis","volume":"26","author":"Hagaman","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0580","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bjc.2017.212","article-title":"The TGF-\u03b2 signalling negative regulator PICK1 represses prostate cancer metastasis to bone","volume":"117","author":"Dai","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0585","first-page":"1159","article-title":"Role of microRNA\/Epithelial-to-mesenchymal transition axis in the metastasis of bladder","volume":"10","author":"Ashrafizadeh","year":"2020","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb0590","first-page":"1040","article-title":"MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy","volume":"10","author":"Ashrafizadeh","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0595","series-title":"Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy","author":"Ashrafizadeh","year":"2021"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0600","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1158\/1535-7163.MCT-16-0391","article-title":"Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma","volume":"15","author":"Dai","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21114002","article-title":"Association of the Epithelial-Mesenchymal Transition (EMT) with cisplatin resistance","volume":"21","author":"Ashrafizadeh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0610","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.21037\/tau.2020.03.02","article-title":"Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-\u03b21\/EMT pathway","volume":"9","author":"Cai","year":"2020","journal-title":"Transl. Androl. Urol."},{"issue":"47","key":"10.1016\/j.ijbiomac.2022.02.094_bb0615","doi-asserted-by":"crossref","first-page":"77124","DOI":"10.18632\/oncotarget.12808","article-title":"TGF-\u03b2 signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0620","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1038\/s41598-017-08249-7","article-title":"DACT1 overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical wnt signalling and autophagy","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0625","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/bcr3399","article-title":"DACT1, an antagonist to Wnt\/\u03b2-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer","volume":"15","author":"Yin","year":"2013","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0630","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41556-021-00641-w","article-title":"TGF-\u03b2-induced DACT1 biomolecular condensates repress wnt signalling to promote bone metastasis","volume":"23","author":"Esposito","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0635","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3892\/ijo.2016.3661","article-title":"Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer","volume":"49","author":"Tang","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118374","article-title":"FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner","volume":"259","author":"Du","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0645","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/pros.23250","article-title":"TGF-\u03b2 effects on prostate cancer cell migration and invasion require FosB","volume":"77","author":"Barrett","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0650","series-title":"The role of SOX Family Transcription Factors in Gastric Cancer","author":"Abadi","year":"2021"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0655","series-title":"Cancer and SOX Proteins: New Insight Into Their Role in Ovarian Cancer Progression\/inhibition","author":"Ashrafizadeh","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0660","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijbiomac.2021.04.185","article-title":"Interplay between SOX9 transcription factor and microRNAs in cancer","volume":"183","author":"Ashrafizadeh","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0665","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.bbrc.2017.10.014","article-title":"PAI-1\/PIAS3\/Stat3\/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in non-small cell lung cancer","volume":"493","author":"Lin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120875","article-title":"The I\u03baB kinase inhibitor ACHP targets the STAT3 signaling pathway in human non-small cell lung carcinoma cells","volume":"9","author":"Lee","year":"2019","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090327","article-title":"The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies","volume":"10","author":"Arora","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0680","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.18632\/oncotarget.3443","article-title":"Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0685","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2013.12.008","article-title":"Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases","volume":"345","author":"Lee","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0690","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.biopha.2018.09.029","article-title":"Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5","volume":"109","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb0695","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ijc.24243","article-title":"DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer","volume":"124","author":"Ma","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0700","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/bjc.2017.372","article-title":"Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-\u03b2-induced epithelial mesenchymal transition through controlling Twist1 expression","volume":"118","author":"Hu","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.02.094_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134786","article-title":"Hypoxia promotes prostate cancer aggressiveness by upregulating EMT-activator Zeb1 and SK3 channel expression","volume":"21","author":"Bery","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0710","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8009","article-title":"Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells","volume":"45","author":"P\u00e9rez","year":"2021","journal-title":"Oncol. Rep."},{"issue":"21","key":"10.1016\/j.ijbiomac.2022.02.094_bb0715","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.7150\/thno.36735","article-title":"Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-\u03b2 signaling","volume":"9","author":"Dai","year":"2019","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0720","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41423-021-00637-4","article-title":"SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061441","article-title":"Androgen deprivation induces reprogramming of prostate cancer cells to stem-like cells","volume":"9","author":"S\u00e1nchez","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0730","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1210\/en.2017-00086","article-title":"Aberrant TGF-\u03b2 signaling drives castration-resistant prostate cancer in a male mouse model of prostate tumorigenesis","volume":"158","author":"Pu","year":"2017","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0735","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/1878-0261.12328","article-title":"miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation","volume":"12","author":"Hoey","year":"2018","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0740","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mc.22913","article-title":"SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties","volume":"58","author":"Yadav","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"16","key":"10.1016\/j.ijbiomac.2022.02.094_bb0745","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/pros.23435","article-title":"Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance","volume":"77","author":"Stark","year":"2017","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00109-014-1206-6","article-title":"TGF-\u03b21 mediates the radiation response of prostate cancer","volume":"93","author":"Wu","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0755","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12935-020-01631-y","article-title":"FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A","volume":"20","author":"Yu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb0760","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41416-020-01105-y","article-title":"Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer","volume":"123","author":"Mout","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188481","article-title":"Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs","volume":"1875","author":"Rizzo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"17","key":"10.1016\/j.ijbiomac.2022.02.094_bb0770","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.7150\/thno.44567","article-title":"TGF-\u03b2 causes docetaxel resistance in prostate cancer via the induction of Bcl-2 by acetylated KLF5 and protein stabilization","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0775","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.gene.2018.11.021","article-title":"Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19","volume":"688","author":"Lin","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0780","series-title":"Long Non-coding RNA in the Doxorubicin Resistance of Cancer Cells","author":"Ashrafizaveh","year":"2021"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.02.094_bb0785","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/0008-5472.CAN-19-2549","article-title":"Loss of a negative feedback loop between IRF8 and AR promotes prostate cancer growth and enzalutamide resistance","volume":"80","author":"Wu","year":"2020","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0790","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/1535-7163.MCT-20-0244","article-title":"Identification of genes required for enzalutamide resistance in castration-resistant prostate cancer cells in vitro","volume":"20","author":"Kohrt","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0795","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pros.23708","article-title":"TGF-\u03b2 receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer","volume":"79","author":"Paller","year":"2019","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0800","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00384-020-03676-x","article-title":"Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression","volume":"35","author":"Ng","year":"2020","journal-title":"Int. J. Color. Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0805","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00384-020-03765-x","article-title":"Metformin usage and the risk of colorectal cancer: a national cohort study","volume":"36","author":"Lee","year":"2021","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117717","article-title":"Anticancer mechanisms of metformin: a review of the current evidence","volume":"254","author":"Zhao","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.417","article-title":"Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-\u03b21\/STAT3 axis-regulated EMT","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0820","series-title":"Seminars in Cancer Biology","article-title":"Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy","author":"Gupta","year":"2020"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb0825","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193220","article-title":"Engineering anti-cancer nanovaccine based on antigen cross-presentation","volume":"39","author":"Warrier","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0830","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/CS20201236","article-title":"Therapeutic targeting of TGF-\u03b2 in cancer: hacking a master switch of immune suppression","volume":"135","author":"van den Bulk","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0835","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/0008-5472.CAN-04-3169","article-title":"Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer","volume":"65","author":"Zhang","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb0840","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/pros.20340","article-title":"Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells","volume":"66","author":"Zhang","year":"2006","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb0845","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/1535-7163.MCT-06-0109","article-title":"Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle","volume":"5","author":"Zhang","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"5860","key":"10.1016\/j.ijbiomac.2022.02.094_bb0850","first-page":"215","article-title":"Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes","volume":"319","author":"Savage","year":"2008"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0855","series-title":"Seminars in Immunology","article-title":"Specificity in cancer immunotherapy","author":"Schietinger","year":"2008"},{"issue":"7055","key":"10.1016\/j.ijbiomac.2022.02.094_bb0860","first-page":"141","article-title":"Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance","volume":"437","author":"Willimsky","year":"2005"},{"issue":"7171","key":"10.1016\/j.ijbiomac.2022.02.094_bb0865","first-page":"903","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0870","first-page":"755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0875","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2011.04.019","article-title":"T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-\u03b21 cytokine","volume":"35","author":"Donkor","year":"2011","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0880","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/onci.1.2.18481","article-title":"Tgf-\u03b21 produced by activated CD4(+) T cells antagonizes T cell surveillance of tumor development","volume":"1","author":"Donkor","year":"2012","journal-title":"Oncoimmunology"},{"issue":"6673","key":"10.1016\/j.ijbiomac.2022.02.094_bb0885","first-page":"245","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0890","first-page":"296","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0895","first-page":"496","article-title":"Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial","volume":"28","author":"Lee","year":"2005"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0900","first-page":"763","article-title":"A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma","volume":"103","author":"Chang","year":"2005"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb0905","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00262-007-0322-3","article-title":"TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer","volume":"56","author":"Wang","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb0910","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ymthe.2018.05.003","article-title":"Dominant-negative TGF-\u03b2 receptor enhances PSMA-targeted human CAR T cell proliferation and augments prostate cancer eradication","volume":"26","author":"Kloss","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0915","series-title":"The role of microRNA-338-3p in cancer: growth, invasion, chemoresistanceand mediators","author":"Mirzaei","year":"2021"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0920","series-title":"MicroRNAs in Cancer Therapy: Their Involvement in Oxaliplatin Sensitivity\/resistance of Cancer Cells With a Focus on Colorectal Cancer","author":"Ashrafizadeh","year":"2020"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0925","series-title":"Interplay Between SOX9 Transcription Factor and MicroRNAs in Cancer","author":"Ashrafizadeh","year":"2021"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0930","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020304","article-title":"Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers","volume":"11","author":"Abadi","year":"2021","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071040","article-title":"MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy","volume":"10","author":"Ashrafizadeh","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb0940","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020246","article-title":"FBXW7 in cancer: what has been unraveled thus far?","volume":"11","author":"Sailo","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.ijbiomac.2022.02.094_bb0945","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/15384101.2020.1777804","article-title":"miR-96-5p regulated TGF-\u03b2\/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1","volume":"19","author":"Chen","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0950","first-page":"1","article-title":"miR-4286 is Involved in Connections Between IGF-1 and TGF-\u03b2 Signaling for the Mesenchymal Transition and Invasion by Glioblastomas","author":"Ho","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0955","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21655979.2019.1710925","article-title":"MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-\u03b21","volume":"11","author":"Chen","year":"2020","journal-title":"Bioengineered"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0960","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2019.01.004","article-title":"miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-\u03b2 signaling","volume":"16","author":"Huang","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0965","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12967-020-02494-7","article-title":"Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in hepatocellular carcinoma","volume":"18","author":"Qin","year":"2020","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb0970","first-page":"4323","article-title":"MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC","volume":"15","author":"Hao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb0975","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41417-020-00237-w","article-title":"microRNA-211-mediated targeting of the INHBA-TGF-\u03b2 axis suppresses prostate tumor formation and growth","volume":"28","author":"Zhao","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb0980","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0985","first-page":"81","article-title":"Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TGF-\u03b2 signaling in prostate cancer","volume":"39","author":"Wa","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb0990","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(92)90219-4","article-title":"A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells","volume":"9","author":"Mori","year":"1992","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb0995","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90298-8","article-title":"REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons","volume":"80","author":"Chong","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb1000","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-006-0102-8","article-title":"Molecular genetic analysis of the REST\/NRSF gene in nervous system tumors","volume":"112","author":"Blom","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1158\/1535-7163.MCT-04-0228","article-title":"Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)\/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16","volume":"4","author":"Fuller","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb1010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41419-018-0807-3","article-title":"Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-\u03b2 signaling","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122762","article-title":"Potent inhibition of miR-34b on migration and invasion in metastatic prostate cancer cells by regulating the TGF-\u03b2 pathway","volume":"18","author":"Fang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1020","series-title":"Dual Relationship Between Long Non-coding RNAs and STAT3 Signaling in Different Cancers: New Insight to Proliferation and Metastasis","author":"Ashrafizadeh","year":"2021"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","article-title":"Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p","volume":"16","author":"Lu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188423","article-title":"The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential","volume":"1874","author":"Pandya","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1035","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061511","article-title":"Mechanistic involvement of long non-coding RNAs in oncotherapeutics resistance in triple-negative breast cancer","volume":"9","author":"Kansara","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb1040","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1002\/jcp.30463","article-title":"Long noncoding RNAs in triple\u2010negative breast cancer: A new frontier in the regulation of tumorigenesis","volume":"236","author":"Thakur","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb1050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2010.03.021","article-title":"Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a","volume":"38","author":"Yap","year":"2010","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/CBM-170683","article-title":"Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a\/TGF-\u03b21\/ Smad signaling pathway","volume":"21","author":"Zhao","year":"2018","journal-title":"Cancer Biomark"},{"issue":"16","key":"10.1016\/j.ijbiomac.2022.02.094_bb1060","first-page":"6849","article-title":"DANCR sponges miR-135a to regulate paclitaxel sensitivity in prostate cancer","volume":"23","author":"Zhao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1065","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.2147\/OTT.S197009","article-title":"Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p\/JAG1 pathway","volume":"12","author":"Ma","year":"2019","journal-title":"Onco. Targets. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb1070","first-page":"2224","article-title":"miR-214-5p targeted by LncRNA DANCR mediates TGF-\u03b2 signaling pathway to accelerate proliferation, migration and inhibit apoptosis of prostate cancer cells","volume":"13","author":"Deng","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1075","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.2147\/CMAR.S231112","article-title":"lncRNA DGCR5 up-regulates TGF-\u03b21, increases cancer cell stemness and predicts survival of prostate cancer patients","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb1080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2012.12.003","article-title":"Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins","volume":"15","author":"Chutiwitoonchai","year":"2013","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri3344","article-title":"The broad-spectrum antiviral functions of IFIT and IFITM proteins","volume":"13","author":"Diamond","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb1090","article-title":"A functional promoter polymorphism of IFITM3 is associated with susceptibility to pediatric tuberculosis inHan Chinese population","volume":"8","author":"Shen","year":"2013"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1095","series-title":"IFITM-family Proteins: The Cell's First Line of Antiviral Defense","first-page":"261","volume":"1","author":"Bailey","year":"2014"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1100","first-page":"238","article-title":"Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3","volume":"14","author":"Wakim","year":"2013"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1105","doi-asserted-by":"crossref","first-page":"8209504","DOI":"10.1155\/2020\/8209504","article-title":"miR-152-3p affects the progression of colon cancer via the KLF4\/IFITM3 Axis","volume":"2020","author":"Zhu","year":"2020","journal-title":"Comput. Math. Methods Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb1110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41419-019-1750-7","article-title":"IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-\u03b2 signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1515\/biol-2021-0022","article-title":"miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer","volume":"16","author":"Wang","year":"2021","journal-title":"Open Life Sci"},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb1120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113312","article-title":"Synthetic MIR143-3p suppresses cell growth in rhabdomyosarcoma cells by interrupting RAS pathways including PAX3-FOXO1","volume":"12","author":"Sugito","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100997","article-title":"Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells","volume":"14","author":"Yoshida","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1130","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-020-0019-8","article-title":"The long non-coding RNA MIAT\/miR-139-5p\/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer","volume":"45","author":"Zeng","year":"2020","journal-title":"J. Biosci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb1135","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/annonc\/mdu454","article-title":"Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death","volume":"25","author":"Birch","year":"2014","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb1140","first-page":"1868","article-title":"Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells","volume":"57","author":"He","year":"1997","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccr.2011.07.008","article-title":"A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression","volume":"20","author":"Yuan","year":"2011","journal-title":"Cancer Cell"},{"issue":"26","key":"10.1016\/j.ijbiomac.2022.02.094_bb1150","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1038\/onc.2015.409","article-title":"Cytoplasmic PML promotes TGF-\u03b2-associated epithelial-mesenchymal transition and invasion in prostate cancer","volume":"35","author":"Buczek","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","article-title":"Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer","volume":"38","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"issue":"26","key":"10.1016\/j.ijbiomac.2022.02.094_bb1160","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.18632\/oncotarget.27650","article-title":"IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells","volume":"11","author":"Mansor","year":"2020","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI122367","article-title":"Targeting FOXA1-mediated repression of TGF-\u03b2 signaling suppresses castration-resistant prostate cancer progression","volume":"129","author":"Song","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1170","first-page":"1017","article-title":"The N domain of Smad7 is essential for specific inhibition of transforming growth factor-\u03b2 signaling","volume":"155","author":"Hanyu","year":"2001"},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb1175","first-page":"1165","article-title":"The MAD-related protein Smad7 associates with the TGF\u03b2 receptor and functions as an antagonist of TGF\u03b2 signaling","volume":"89","author":"Hayashi","year":"1997"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1180","first-page":"30","article-title":"In vitro and in vivo imaging of prostate cancer angiogenesis using anti-vascular endothelial growth factor receptor 2 antibody-conjugated quantum dot","volume":"14","author":"Kwon","year":"2013"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb1185","article-title":"TGF-\u03b2 and the TGF-\u03b2 family: context-dependent roles in cell and tissue physiology","volume":"8","author":"Morikawa","year":"2016"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101470","article-title":"Smad7 enhances TGF-\u03b2-induced transcription of c-Jun and HDAC6 promoting invasion of prostate cancer cells","volume":"23","author":"Thakur","year":"2020","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb1195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mi.3.5.281","article-title":"Estrogen signaling: a subtle balance between ER alpha and ER beta","volume":"3","author":"Matthews","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1746-1596-9-20","article-title":"Significance of ER\u03b2 expression in different molecular subtypes of breast cancer","volume":"9","author":"Guo","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"42","key":"10.1016\/j.ijbiomac.2022.02.094_bb1205","doi-asserted-by":"crossref","first-page":"26347","DOI":"10.1073\/pnas.2007160117","article-title":"Estrogen receptor \u03b2 regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3","volume":"117","author":"Chaurasiya","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.02.094_bb1210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011269118","article-title":"Estrogen receptor \u03b2 and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate","volume":"118","author":"Wu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.02.094_bb1215","first-page":"8569","article-title":"Estrogen receptor \u03b2 inhibits prostate cancer cell proliferation through downregulating TGF-\u03b21\/IGF-1 signaling","volume":"10","author":"Xiao","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1220","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1038\/s41598-019-44685-3","article-title":"Relationship between ETS transcription factor ETV1 and TGF-\u03b2-regulated SMAD proteins in prostate cancer","volume":"9","author":"Oh","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2018.05.183","article-title":"RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-\u03b21","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.02.094_bb1230","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1878-0261.12634","article-title":"SMAD3\/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-\u03b2 signaling promotes prostate cancer bone metastasis","volume":"14","author":"Lang","year":"2020","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.15171\/apb.2019.058","article-title":"The effects of thymoquinone on viability, and anti-apoptotic factors (BCL-XL, BCL-2, MCL-1) in prostate cancer (PC3) cells: an in vitro and computer-simulated environment study","volume":"9","author":"Saffari Chaleshtori","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1240","first-page":"1403","article-title":"Thymoquinone inhibits IL\u20107\u2010induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt\/NF\u2010\u03baB signaling","volume":"68","author":"Alshyarba","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb1245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091390","article-title":"Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway","volume":"11","author":"Singh","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1250","first-page":"3592","article-title":"Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"38","author":"Kou","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172551","article-title":"Up-regulation of TIF1\u03b3 by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-\u03b2\/Smad signaling pathway","volume":"860","author":"Qi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105831","article-title":"Regulation of anti-tumorigenic pathways by the combinatory treatment of calcitriol and TGF-\u03b2 in PC-3 and DU145 cells","volume":"209","author":"Garc\u00eda-Olivares","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pros.10059","article-title":"Growth inhibition of prostate cancer xenografts by halofuginone","volume":"51","author":"Gavish","year":"2002","journal-title":"Prostate"},{"issue":"4 Pt 2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1270","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/01.ju.0000179218.16587.d2","article-title":"Inhibition of wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expression","volume":"174","author":"Pinthus","year":"2005","journal-title":"J. Urol."},{"issue":"49","key":"10.1016\/j.ijbiomac.2022.02.094_bb1275","doi-asserted-by":"crossref","first-page":"86447","DOI":"10.18632\/oncotarget.21200","article-title":"Halofuginone inhibits TGF-\u03b2\/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis","volume":"8","author":"Ju\u00e1rez","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1280","first-page":"1065","article-title":"Verbascoside\u2014A review of its occurrence,(bio) synthesis and pharmacological significance","volume":"32","author":"Alipieva","year":"2014"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/1471-2407-14-747","article-title":"Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer","volume":"14","author":"Zhou","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1290","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/tox.23107","article-title":"Verbascoside inhibits the epithelial-mesenchymal transition of prostate cancer cells through high-mobility group box 1\/receptor for advanced glycation end-products\/TGF-\u03b2 pathway","volume":"36","author":"Wu","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb1295","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10637-019-00727-1","article-title":"The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-\u03b21, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers","volume":"37","author":"Collery","year":"2019","journal-title":"Investig. New Drugs"},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2022.02.094_bb1300","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbrc.2017.10.138","article-title":"Galangin enhances TGF-\u03b21-mediated growth inhibition by suppressing phosphorylation of threonine 179 residue in Smad3 linker region","volume":"494","author":"Kwak","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.02.094_bb1305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061896","article-title":"Critical role of a survivin\/TGF-\u03b2\/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1310","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000430139","article-title":"Periostin mediates TGF-\u03b2-induced epithelial mesenchymal transition in prostate cancer cells","volume":"36","author":"Hu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.02.094_bb1315","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2012.582","article-title":"Dp44mT targets the AKT, TGF-\u03b2 and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells","volume":"108","author":"Dixon","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"41","key":"10.1016\/j.ijbiomac.2022.02.094_bb1320","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1038\/sj.onc.1209571","article-title":"ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta\/Smad-induced growth arrest of prostate cells","volume":"25","author":"Noda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1325","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/398253","article-title":"Skip regulates TGF- \u03b2 1-induced extracellular matrix degrading proteases expression in human PC-3 prostate cancer cells","volume":"2013","author":"Villar","year":"2013","journal-title":"Prostate Cancer"},{"issue":"34","key":"10.1016\/j.ijbiomac.2022.02.094_bb1330","doi-asserted-by":"crossref","first-page":"17964","DOI":"10.1074\/jbc.M116.714899","article-title":"JunD is required for proliferation of prostate cancer cells and plays a role in transforming growth factor-\u03b2 (TGF-\u03b2)-induced inhibition of cell proliferation","volume":"291","author":"Millena","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060165","article-title":"CRISPR-mediated reactivation of DKK3 expression attenuates TGF-\u03b2 signaling in prostate cancer","volume":"10","author":"Kardooni","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1340","doi-asserted-by":"crossref","first-page":"12987","DOI":"10.2147\/OTT.S281962","article-title":"MiR-519d and miR-328-3p combinatorially suppress breast cancer progression","volume":"13","author":"Ma","year":"2020","journal-title":"Onco. Targets. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.02.094_bb1345","first-page":"1143","article-title":"Tgf-\u03b21 expression as a biomarker of poor prognosis in prostate cancer","volume":"66","author":"Reis","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1350","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.canep.2010.03.019","article-title":"COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67","volume":"34","author":"Richardsen","year":"2010","journal-title":"Cancer Epidemiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2022.02.094_bb1355","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.2001.19.11.2856","article-title":"Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy","volume":"19","author":"Shariat","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"486","key":"10.1016\/j.ijbiomac.2022.02.094_bb1360","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal4186","article-title":"TGF-\u03b2 promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85\u03b1","volume":"10","author":"Hamidi","year":"2017","journal-title":"Sci. Signal."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.02.094_bb1365","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/pros.23837","article-title":"The metastasis suppressor CD82\/KAI1 represses the TGF-\u03b2 (1) and wnt signalings inducing epithelial-to-mesenchymal transition linked to invasiveness of prostate cancer cells","volume":"79","author":"Lee","year":"2019","journal-title":"Prostate"},{"issue":"16","key":"10.1016\/j.ijbiomac.2022.02.094_bb1370","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/pros.23241","article-title":"MicroRNA-132\/212 upregulation inhibits TGF-\u03b2-mediated epithelial-mesenchymal transition of prostate cancer cells by targeting SOX4","volume":"76","author":"Fu","year":"2016","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb1375","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1111\/jcmm.14402","article-title":"MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-\u03b2\/Smad4 signalling pathway by down-regulating DLX1","volume":"23","author":"Sun","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2022.02.094_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.139234","article-title":"Endosulfan triggers epithelial-mesenchymal transition via PTP4A3-mediated TGF-\u03b2 signaling pathway in prostate cancer cells","volume":"731","author":"Wang","year":"2020","journal-title":"Sci. Total Environ."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb1385","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12094-018-1862-z","article-title":"Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-\u03b2 signaling","volume":"20","author":"Wu","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1390","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1515\/med-2020-0221","article-title":"NANOG regulates the proliferation of PCSCs via the TGF-\u03b21\/SMAD pathway","volume":"15","author":"Liu","year":"2020","journal-title":"Open Med (Wars)"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.02.094_bb1395","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/stem.2412","article-title":"Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-\u03b21","volume":"34","author":"Barcellos-de-Souza","year":"2016","journal-title":"Stem Cells"},{"issue":"52","key":"10.1016\/j.ijbiomac.2022.02.094_bb1400","doi-asserted-by":"crossref","first-page":"86087","DOI":"10.18632\/oncotarget.13343","article-title":"A novel highly potent trivalent TGF-\u03b2 receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine pten-deficient prostate glands","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1405","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cryobiol.2016.05.011","article-title":"Perioperative changes in TGF-\u03b21 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer","volume":"73","author":"Wang","year":"2016","journal-title":"Cryobiology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.02.094_bb1410","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/15384101.2021.1909242","article-title":"BZW1 promotes cell proliferation in prostate cancer by regulating TGF-\u03b21\/Smad pathway","volume":"20","author":"Shi","year":"2021","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.02.094_bb1415","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41416-020-01135-6","article-title":"Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9\/STAT3 signalling pathway","volume":"124","author":"Yang","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1420","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-018-04042-w","article-title":"Frizzled-8 integrates Wnt-11 and transforming growth factor-\u03b2 signaling in prostate cancer","volume":"9","author":"Murillo-Garz\u00f3n","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.02.094_bb1425","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jcb.27446","article-title":"ETS1 induces transforming growth factor \u03b2 signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells","volume":"120","author":"Rodgers","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.02.094_bb1430","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/pros.23489","article-title":"Osteoblast-derived factors promote metastatic potential in human prostate cancer cells, in part via non-canonical transforming growth factor \u03b2 (TGF\u03b2) signaling","volume":"78","author":"Karlsson","year":"2018","journal-title":"Prostate"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022003403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022003403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:29:55Z","timestamp":1758878995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022003403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":286,"alternative-id":["S0141813022003403"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.094","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming growth factor-beta (TGF-\u03b2) in prostate cancer: A dual function mediator?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}